
<div class="card-body card-padding">
    <h3 class="md-title">Contact</h3>
    <p>
      For detailed methodology and protocol, please contact the Center for Advanced Molecular Diagnostics (857-307-1500).
    </p>
    <h3 class="md-title">
      References
    </h3>
    <p>
     <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353152/">Wagle et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov. 2012</a>
    </p>
    <p>
      These tests were developed and their performance characteristics determined by the Molecular Diagnostics Laboratory, Brigham and Womenâ€™s Hospital. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
    </p>
</div>
